Aperio Group’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.84M | Buy |
40,111
+9,620
| +32% | +$441K | 0.01% | 1283 |
|
|
2020
Q3 | $1.01M | Sell |
30,491
-2,515
| -8% | -$83.6K | ﹤0.01% | 1438 |
|
|
2020
Q2 | $970K | Sell |
33,006
-10,999
| -25% | -$323K | ﹤0.01% | 1425 |
|
|
2020
Q1 | $1.19M | Buy |
44,005
+16,402
| +59% | +$442K | 0.01% | 1236 |
|
|
2019
Q4 | $930K | Buy |
27,603
+2,388
| +9% | +$80.5K | ﹤0.01% | 1470 |
|
|
2019
Q3 | $945K | Sell |
25,215
-3,166
| -11% | -$119K | ﹤0.01% | 1422 |
|
|
2019
Q2 | $1.24M | Sell |
28,381
-2,965
| -9% | -$129K | 0.01% | 1296 |
|
|
2019
Q1 | $1.34M | Sell |
31,346
-3,726
| -11% | -$159K | 0.01% | 1216 |
|
|
2018
Q4 | $1.57M | Sell |
35,072
-3,816
| -10% | -$171K | 0.01% | 1085 |
|
|
2018
Q3 | $2.66M | Buy |
38,888
+1,427
| +4% | +$97.8K | 0.01% | 905 |
|
|
2018
Q2 | $2.15M | Buy |
37,461
+2,106
| +6% | +$121K | 0.01% | 998 |
|
|
2018
Q1 | $1.63M | Buy |
35,355
+1,474
| +4% | +$67.9K | 0.01% | 1086 |
|
|
2017
Q4 | $1.57M | Buy |
33,881
+1,607
| +5% | +$74.2K | 0.01% | 1095 |
|
|
2017
Q3 | $1.45M | Buy |
32,274
+2,212
| +7% | +$99.6K | 0.01% | 1077 |
|
|
2017
Q2 | $1.18M | Buy |
30,062
+1,991
| +7% | +$78.2K | 0.01% | 1151 |
|
|
2017
Q1 | $1.07M | Buy |
28,071
+898
| +3% | +$34.2K | 0.01% | 1142 |
|
|
2016
Q4 | $1.01M | Buy |
27,173
+5,021
| +23% | +$186K | 0.01% | 1126 |
|
|
2016
Q3 | $768K | Buy |
22,152
+3,758
| +20% | +$130K | 0.01% | 1229 |
|
|
2016
Q2 | $598K | Buy |
18,394
+2,342
| +15% | +$76.1K | ﹤0.01% | 1291 |
|
|
2016
Q1 | $461K | Buy |
16,052
+556
| +4% | +$16K | ﹤0.01% | 1406 |
|
|
2015
Q4 | $518K | Sell |
15,496
-171
| -1% | -$5.72K | ﹤0.01% | 1323 |
|
|
2015
Q3 | $446K | Sell |
15,667
-5,880
| -27% | -$167K | ﹤0.01% | 1364 |
|
|
2015
Q2 | $873K | Buy |
21,547
+1,128
| +6% | +$45.7K | 0.01% | 1036 |
|
|
2015
Q1 | $1.01M | Sell |
20,419
-1,299
| -6% | -$63.9K | 0.01% | 937 |
|
|
2014
Q4 | $988K | Buy |
+21,718
| New | +$988K | 0.01% | 913 |
|